We narrowed to 9,634 results for: SUB

1. pDONR223_PSMG1_WT_V5

   Plasmid

   #82954

   Purpose

   Gateway Donor vector containing PSMG1, used as an over expression control for gene expression analysis. Part of the Target Accelerator Plasmid Collection.

   Depositor

   Jesse Boehm, David Root, Matthew Meyerson

   Article

   Berger et al Cancer Cell. 2016 Aug 8;30(2):214-28. do

   Insert

   PSMG1 (PSMG1 Human)
   

   Use

   Gateway entry vector

   Promoter

   None

   Available Since

   April 24, 2017

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

2. Anti-Flrt3 [N353/13R]

   Plasmid

   #114486

   Purpose

   Mammalian Expression Plasmid of anti-Flrt3 (Mouse). Derived from hybridoma N353/13.

   Depositor

   James Trimmer

   Article

   Andrews et al eLife. 2019 Jan 22;8. pii: 43322. doi: 1

   Insert

   anti-Flrt3 (Mus musculus) recombinant mouse monoclonal antibody (Flrt3 Mouse)
   

   Expression

   Mammalian

   Promoter

   dual CMV

   Available Since

   Feb. 21, 2019

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

3. Anti-Kv4.2 K+ channel [L28/4R]

   Plasmid

   #149453

   Purpose

   Mammalian Expression Plasmid of anti-Kv4.2 K+ channel (Rat). Derived from hybridoma L28/4.

   Depositor

   James Trimmer

   Article

   Andrews et al eLife. 2019 Jan 22;8. pii: 43322. doi: 1

   Insert

   anti-Kv4.2 K+ channel (Rattus norvegicus) recombinant mouse monoclonal antibody (Kcnd2 Mouse)
   

   Expression

   Mammalian

   Promoter

   Dual CMV

   Available Since

   June 26, 2020

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

4. pDONR223_RHOA_p.T19N

   Plasmid

   #82182

   Purpose

   Gateway Donor vector containing RHOA , part of the Target Accelerator Plasmid Collection.

   Depositor

   Jesse Boehm, William Hahn, David Root

   Article

   Kim et al Cancer Discov. 2016 Jul;6(7):714-26. doi

   Insert

   RHOA (RHOA Human)
   

   Use

   Gateway entry vector

   Mutation

   T19N

   Promoter

   None

   Available Since

   April 24, 2017

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

5. Anti-INPP4b [N171/17.4R]

   Plasmid

   #114551

   Purpose

   Mammalian Expression Plasmid of anti-INPP4b (Human). Derived from hybridoma N171/17.4.

   Depositor

   James Trimmer

   Article

   Andrews et al eLife. 2019 Jan 22;8. pii: 43322. doi: 1

   Insert

   anti-INPP4b (Homo sapiens) recombinant mouse monoclonal antibody (INPP4B Mouse)
   

   Expression

   Mammalian

   Promoter

   dual CMV

   Available Since

   Feb. 26, 2019

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

6. pDONR223_IKBKE_WT

   Plasmid

   #82248

   Purpose

   Gateway Donor vector containing IKBKE, part of the Target Accelerator Plasmid Collection.

   Depositor

   Jesse Boehm, William Hahn, David Root

   Article

   Kim et al Cancer Discov. 2016 Jul;6(7):714-26. doi

   Insert

   IKBKE (IKBKE Human)
   

   Use

   Gateway entry vector

   Mutation

   WT

   Promoter

   None

   Available Since

   April 24, 2017

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

7. pDONR223_EGFR_p.Q1020H

   Plasmid

   #82812

   Purpose

   Gateway Donor vector containing EGFR, part of the Target Accelerator Plasmid Collection.

   Depositor

   Jesse Boehm, David Root, Matthew Meyerson

   Article

   Berger et al Cancer Cell. 2016 Aug 8;30(2):214-28. do

   Insert

   EGFR (EGFR Human)
   

   Use

   Gateway entry vector

   Mutation

   Q1020H

   Promoter

   None

   Available Since

   April 24, 2017

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

8. pDONR223_KEAP1_p.G417R

   Plasmid

   #82836

   Purpose

   Gateway Donor vector containing KEAP1, part of the Target Accelerator Plasmid Collection.

   Depositor

   Jesse Boehm, David Root, Matthew Meyerson

   Article

   Berger et al Cancer Cell. 2016 Aug 8;30(2):214-28. do

   Insert

   KEAP1 (KEAP1 Human)
   

   Use

   Gateway entry vector

   Mutation

   G417R; C624S

   Promoter

   None

   Available Since

   April 24, 2017

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

9. pDONR223_AKT1_p.L52R

   Plasmid

   #81604

   Purpose

   Gateway Donor vector containing AKT1 , part of the Target Accelerator Plasmid Collection.

   Depositor

   Jesse Boehm, William Hahn, David Root

   Article

   Kim et al Cancer Discov. 2016 Jul;6(7):714-26. doi

   Insert

   AKT1 (AKT1 Human)
   

   Use

   Gateway entry vector

   Mutation

   L52R

   Promoter

   None

   Available Since

   April 24, 2017

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

10. pDONR223_MTERFD1_WT_V5

    Plasmid

    #82966

    Purpose

    Gateway Donor vector containing MTERFD1, used as an over expression control for gene expression analysis. Part of the Target Accelerator Plasmid Collection.

    Depositor

    Jesse Boehm, David Root, Matthew Meyerson

    Article

    Berger et al Cancer Cell. 2016 Aug 8;30(2):214-28. do

    Insert

    MTERF3 (MTERF3 Human)
    

    Use

    Gateway entry vector

    Promoter

    None

    Available Since

    April 24, 2017

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

11. pDONR223_TP53_p.C275F

    Plasmid

    #81399

    Purpose

    Gateway Donor vector containing TP53 , part of the Target Accelerator Plasmid Collection.

    Depositor

    Jesse Boehm, William Hahn, David Root

    Article

    Kim et al Cancer Discov. 2016 Jul;6(7):714-26. doi

    Insert

    TP53 (TP53 Human)
    

    Use

    Gateway entry vector

    Mutation

    P72R; C275F; P278A

    Promoter

    None

    Available Since

    April 24, 2017

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

12. pDONR223_FAM196A_WT

    Plasmid

    #81882

    Purpose

    Gateway Donor vector containing FAM196A , part of the Target Accelerator Plasmid Collection.

    Depositor

    Jesse Boehm, William Hahn, David Root

    Article

    Kim et al Cancer Discov. 2016 Jul;6(7):714-26. doi

    Insert

    FAM196A (FAM196A Human)
    

    Use

    Gateway entry vector

    Mutation

    WT

    Promoter

    None

    Available Since

    April 24, 2017

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

13. Anti-NGL-3/LRRC4B [N51/6.2R]

    Plasmid

    #114493

    Purpose

    Mammalian Expression Plasmid of anti-NGL-3/LRRC4B (Rat). Derived from hybridoma N51/6.2.

    Depositor

    James Trimmer

    Article

    Andrews et al eLife. 2019 Jan 22;8. pii: 43322. doi: 1

    Insert

    anti-NGL-3/LRRC4B (Rattus norvegicus) recombinant mouse monoclonal antibody (Lrrc4b Mouse)
    

    Expression

    Mammalian

    Promoter

    dual CMV

    Available Since

    Feb. 28, 2020

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

14. pDONR223_SERPINB5_WT

    Plasmid

    #82898

    Purpose

    Gateway Donor vector containing SERPINB5, part of the Target Accelerator Plasmid Collection.

    Depositor

    Jesse Boehm, David Root, Matthew Meyerson

    Article

    Berger et al Cancer Cell. 2016 Aug 8;30(2):214-28. do

    Insert

    SERPINB5 (SERPINB5 Human)
    

    Use

    Gateway entry vector

    Mutation

    S176P; AA190-192delTDTins25;AA194-196delPVQinsSIP…

    Promoter

    None

    Available Since

    April 24, 2017

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

15. pDONR223_GLIPR1_WT

    Plasmid

    #81780

    Purpose

    Gateway Donor vector containing GLIPR1 , part of the Target Accelerator Plasmid Collection.

    Depositor

    Jesse Boehm, William Hahn, David Root

    Article

    Kim et al Cancer Discov. 2016 Jul;6(7):714-26. doi

    Insert

    GLIPR1 (GLIPR1 Human)
    

    Use

    Gateway entry vector

    Mutation

    WT

    Promoter

    None

    Available Since

    April 24, 2017

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

16. pVRC8400-SARS-CoV-2-NTD-BA.2-AVI

    Plasmid

    #184532

    Purpose

    Expresses SARS-CoV-2 NTD domain from the BA.2 variant with single chain Fc, HRV3C protease cleavage site, and AVI tag

    Depositor

    Peter Kwong

    Article

    Teng et al PLoS One. 2022 May 24;17(5):e0268767. do

    Insert

    SARS-CoV-2-NTD-BA.2 (S )
    

    Tags

    AVI, HRV3C, and scFc

    Expression

    Mammalian

    Mutation

    T19I, L24-, P25-, P26-, A27S, G142D, V213G

    Available Since

    May 10, 2022

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

17. pVRC8400-SARS-CoV-2-S2P-B.1.351-AVI

    Plasmid

    #176326

    Purpose

    Expresses SARS-CoV-2 S2P protein from the B.1.351 variant with single chain Fc, HRV3C protease cleavage site, and AVI tag

    Depositor

    Peter Kwong

    Article

    Teng et al PLoS One. 2022 May 24;17(5):e0268767. do

    Insert

    SARS-CoV-2-S2P-B.1.351 (S )
    

    Tags

    AVI, HRV3C, and scFc

    Expression

    Mammalian

    Mutation

    L18F, D80A, D215G, 242-244del, R246I, K417N, E484…

    Available Since

    March 2, 2022

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

18. pDONR223_FAIM_WT_V5

    Plasmid

    #82930

    Purpose

    Gateway Donor vector containing FAIM, used as an over expression control for gene expression analysis. Part of the Target Accelerator Plasmid Collection.

    Depositor

    Jesse Boehm, David Root, Matthew Meyerson

    Article

    Berger et al Cancer Cell. 2016 Aug 8;30(2):214-28. do

    Insert

    FAIM (FAIM Human)
    

    Use

    Gateway entry vector

    Promoter

    None

    Available Since

    April 24, 2017

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

19. Anti-PSD-93/Chapsyn-110 [N18/30R]

    Plasmid

    #177506

    Purpose

    Mammalian Expression Plasmid of anti-PSD-93/Chapsyn-110 (Rat). Derived from hybridoma N18/30.

    Depositor

    James Trimmer

    Article

    Andrews et al eLife. 2019 Jan 22;8. pii: 43322. doi: 1

    Insert

    anti-PSD-93/Chapsyn-110 (Rattus norvegicus) recombinant mouse monoclonal antibody (Dlg2 Mouse)
    

    Expression

    Mammalian

    Promoter

    Dual CMV

    Available Since

    Nov. 29, 2021

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

20. pDONR223_H2AFX_p.K134N

    Plasmid

    #81275

    Purpose

    Gateway Donor vector containing H2AFX , part of the Target Accelerator Plasmid Collection.

    Depositor

    Jesse Boehm, William Hahn, David Root

    Article

    Kim et al Cancer Discov. 2016 Jul;6(7):714-26. doi

    Insert

    H2AFX (H2AX Human)
    

    Use

    Gateway entry vector

    Mutation

    K134N

    Promoter

    None

    Available Since

    April 24, 2017

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

21. pDONR223_ACD_WT_V5

    Plasmid

    #83001

    Purpose

    Gateway Donor vector containing ACD, used as an over expression control for gene expression analysis. Part of the Target Accelerator Plasmid Collection.

    Depositor

    Jesse Boehm, David Root, Matthew Meyerson

    Article

    Berger et al Cancer Cell. 2016 Aug 8;30(2):214-28. do

    Insert

    ACD (ACD Human)
    

    Use

    Gateway entry vector

    Mutation

    V518A

    Promoter

    None

    Available Since

    April 24, 2017

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

22. pDONR223_REG3A_WT

    Plasmid

    #81826

    Purpose

    Gateway Donor vector containing REG3A , part of the Target Accelerator Plasmid Collection.

    Depositor

    Jesse Boehm, William Hahn, David Root

    Article

    Kim et al Cancer Discov. 2016 Jul;6(7):714-26. doi

    Insert

    REG3A (REG3A Human)
    

    Use

    Gateway entry vector

    Mutation

    WT

    Promoter

    None

    Available Since

    April 24, 2017

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

23. pVRC8400-SARS-CoV-2-NTD-P.1-AVI

    Plasmid

    #176429

    Purpose

    Expresses SARS-CoV-2 NTD domain from the P.1 variant with single chain Fc, HRV3C protease cleavage site, and AVI tag

    Depositor

    Peter Kwong

    Article

    Teng et al PLoS One. 2022 May 24;17(5):e0268767. do

    Insert

    SARS-CoV-2-NTD-P.1 (S )
    

    Tags

    AVI, HRV3C, and scFc

    Expression

    Mammalian

    Mutation

    L18F, T20N, P26S, D138Y, R190S

    Available Since

    March 2, 2022

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

24. pVRC8400-SARS-CoV-2-S2P-P.1-AVI

    Plasmid

    #176327

    Purpose

    Expresses SARS-CoV-2 S2P protein from the P.1 variant with single chain Fc, HRV3C protease cleavage site, and AVI tag

    Depositor

    Peter Kwong

    Article

    Teng et al PLoS One. 2022 May 24;17(5):e0268767. do

    Insert

    SARS-CoV-2-S2P-P.1 (S )
    

    Tags

    AVI, HRV3C, and scFc

    Expression

    Mammalian

    Mutation

    L18F, T20N, P26S, D138Y, R190S, K417T, E484K, N50…

    Available Since

    March 2, 2022

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

25. pDONR223_XPO1_p.E571K

    Plasmid

    #81554

    Purpose

    Gateway Donor vector containing XPO1 , part of the Target Accelerator Plasmid Collection.

    Depositor

    Jesse Boehm, William Hahn, David Root

    Article

    Kim et al Cancer Discov. 2016 Jul;6(7):714-26. doi

    Insert

    XPO1 (XPO1 Human)
    

    Use

    Gateway entry vector

    Mutation

    E571K

    Promoter

    None

    Available Since

    April 24, 2017

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

26. pDONR223_PIK3CA_p.D1045V

    Plasmid

    #81702

    Purpose

    Gateway Donor vector containing PIK3CA, part of the Target Accelerator Plasmid Collection.

    Depositor

    Jesse Boehm, William Hahn, David Root

    Article

    Kim et al Cancer Discov. 2016 Jul;6(7):714-26. doi

    Insert

    PIK3CA (PIK3CA Human)
    

    Use

    Gateway entry vector

    Mutation

    D1045V

    Promoter

    None

    Available Since

    April 24, 2017

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

27. nCas9-UGI control for Target-AID (pRZ1047)

    Plasmid

    #131299

    Purpose

    CAG promoter expression plasmid for NLS-hSpCas9n(D10A)-NLS-SH3-3xFLAG-NLS-UGI-P2A-EGFP (Target-AID without pmCDA1).

    Depositor

    Keith Joung

    Article

    Grunewald et al Nat Biotechnol. 2019 Sep 2. pii: 10.1038

    Insert

    NLS-hSpCas9n(D10A)-NLS-SH3-3xFLAG-NLS-UGI-P2A-EGFP
    

    Expression

    Mammalian

    Promoter

    CAG

    Available Since

    Oct. 24, 2019

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

28. Anti-Kvbeta2/KCNAB2 K+ channel [K17/70R]

    Plasmid

    #128615

    Purpose

    Mammalian Expression Plasmid of anti-Kvbeta2/KCNAB2 K+ channel (Mouse). Derived from hybridoma K17/70.

    Depositor

    James Trimmer

    Article

    Andrews et al eLife. 2019 Jan 22;8. pii: 43322. doi: 1

    Insert

    anti-Kvbeta2/KCNAB2 K+ Channel (Mouse) recombinant mouse monoclonal antibody (Kcnab2 Mouse)
    

    Expression

    Mammalian

    Promoter

    Dual CMV

    Available Since

    Sept. 20, 2019

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

29. pDONR223_ACVR1B_WT

    Plasmid

    #81738

    Purpose

    Gateway Donor vector containing ACVR1B , part of the Target Accelerator Plasmid Collection.

    Depositor

    Jesse Boehm, William Hahn, David Root

    Article

    Kim et al Cancer Discov. 2016 Jul;6(7):714-26. doi

    Insert

    ACVR1B (ACVR1B Human)
    

    Use

    Gateway entry vector

    Mutation

    WT

    Promoter

    None

    Available Since

    April 24, 2017

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

30. pDONR223_MAP2K1_WT

    Plasmid

    #81920

    Purpose

    Gateway Donor vector containing MAP2K1 , part of the Target Accelerator Plasmid Collection.

    Depositor

    Jesse Boehm, William Hahn, David Root

    Article

    Kim et al Cancer Discov. 2016 Jul;6(7):714-26. doi

    Insert

    MAP2K1 (MAP2K1 Human)
    

    Use

    Gateway entry vector

    Mutation

    I310N

    Promoter

    None

    Available Since

    April 24, 2017

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

31. pDONR223_MYC_p.E366Q

    Plasmid

    #82819

    Purpose

    Gateway Donor vector containing MYC, part of the Target Accelerator Plasmid Collection.

    Depositor

    Jesse Boehm, David Root, Matthew Meyerson

    Article

    Berger et al Cancer Cell. 2016 Aug 8;30(2):214-28. do

    Insert

    MYC (MYC Human)
    

    Use

    Gateway entry vector

    Mutation

    L1M; E366Q

    Promoter

    None

    Available Since

    April 24, 2017

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

32. pDONR223_WIPI1_WT

    Plasmid

    #82055

    Purpose

    Gateway Donor vector containing WIPI1 , part of the Target Accelerator Plasmid Collection.

    Depositor

    Jesse Boehm, William Hahn, David Root

    Article

    Kim et al Cancer Discov. 2016 Jul;6(7):714-26. doi

    Insert

    WIPI1 (WIPI1 Human)
    

    Use

    Gateway entry vector

    Mutation

    T31I

    Promoter

    None

    Available Since

    April 24, 2017

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

33. pDONR223_FCGR3B_p.L218P

    Plasmid

    #82746

    Purpose

    Gateway Donor vector containing FCGR3B, part of the Target Accelerator Plasmid Collection.

    Depositor

    Jesse Boehm, David Root, Matthew Meyerson

    Article

    Berger et al Cancer Cell. 2016 Aug 8;30(2):214-28. do

    Insert

    FCGR3B (FCGR3B Human)
    

    Use

    Gateway entry vector

    Mutation

    N65S; L218P

    Promoter

    None

    Available Since

    April 24, 2017

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

34. Anti-FGF12/FHF1 [N94/17R]

    Plasmid

    #114538

    Purpose

    Mammalian Expression Plasmid of anti-FGF12/FHF1 (Human). Derived from hybridoma N94/17.

    Depositor

    James Trimmer

    Article

    Andrews et al eLife. 2019 Jan 22;8. pii: 43322. doi: 1

    Insert

    anti-FGF12/FHF1 (Homo sapiens) recombinant mouse monoclonal antibody (FGF12 Mouse)
    

    Expression

    Mammalian

    Promoter

    dual CMV

    Available Since

    Feb. 26, 2019

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

35. Anti-FGF13/FHF2 [N91/27.1R]

    Plasmid

    #114525

    Purpose

    Mammalian Expression Plasmid of anti-FGF13/FHF2 (Human). Derived from hybridoma N91/27.1.

    Depositor

    James Trimmer

    Article

    Andrews et al eLife. 2019 Jan 22;8. pii: 43322. doi: 1

    Insert

    anti-FGF13/FHF2 (Homo sapiens) recombinant mouse monoclonal antibody (FGF13 Mouse)
    

    Expression

    Mammalian

    Promoter

    dual CMV

    Available Since

    Sept. 25, 2018

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

36. Anti-Kv2.1 K+ channel [L61C/30R]

    Plasmid

    #177487

    Purpose

    Mammalian Expression Plasmid of anti-Kv2.1 K+ channel (Rat). Derived from hybridoma L61C/30.

    Depositor

    James Trimmer

    Article

    Andrews et al eLife. 2019 Jan 22;8. pii: 43322. doi: 1

    Insert

    anti-Kv2.1 K+ channel (Rattus norvegicus) recombinant mouse monoclonal antibody (Kcnb1 Mouse)
    

    Expression

    Mammalian

    Promoter

    Dual CMV

    Available Since

    Nov. 15, 2021

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

37. pDONR223_TCF7L2_WT

    Plasmid

    #81745

    Purpose

    Gateway Donor vector containing TCF7L2 , part of the Target Accelerator Plasmid Collection.

    Depositor

    Jesse Boehm, William Hahn, David Root

    Article

    Kim et al Cancer Discov. 2016 Jul;6(7):714-26. doi

    Insert

    TCF7L2 (TCF7L2 Human)
    

    Use

    Gateway entry vector

    Mutation

    WT

    Promoter

    None

    Available Since

    April 24, 2017

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

38. YFP(1-158)-gamma-2 in pcDNAI/Amp

    Plasmid

    #55762

    Purpose

    An amino-terminal YFP fragment was fused to Ggamma2. When co-expressed with a carboxyl terminal YFP or CFP fragment fused to a Gbeta subunit with which it interacts, a fluorescent signal is produced.

    Depositor

    Catherine Berlot

    Article

    Yost et al Mol Pharmacol. 2007 Oct;72(4):812-25. Ep

    Insert

    YFP(1-158)-gamma-2 (GNG2 Aequorea victoria, Human)
    

    Tags

    YFP(1-158) was fused to the amino terminus of Gga…

    Expression

    Mammalian

    Mutation

    YFP (1-158) includes a substitution of Met for Gl…

    Promoter

    CMV

    Available Since

    July 30, 2015

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

39. Anti-BK beta4 K+ channel [L18A/3R]

    Plasmid

    #149454

    Purpose

    Mammalian Expression Plasmid of anti-BK beta4 K+ channel (Mouse). Derived from hybridoma L18A/3.

    Depositor

    James Trimmer

    Article

    Andrews et al eLife. 2019 Jan 22;8. pii: 43322. doi: 1

    Insert

    anti-BK beta4 K+ channel (Mus musculus) recombinant mouse monoclonal antibody (Kcnmb4 Mouse)
    

    Expression

    Mammalian

    Promoter

    Dual CMV

    Available Since

    June 26, 2020

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

40. pDONR223_CTNNB1_p.D162E

    Plasmid

    #81732

    Purpose

    Gateway Donor vector containing , part of the Target Accelerator Plasmid Collection.

    Depositor

    Jesse Boehm, William Hahn, David Root

    Article

    Kim et al Cancer Discov. 2016 Jul;6(7):714-26. doi

    Insert

    CTNNB1 (CTNNB1 Human)
    

    Use

    Gateway entry vector

    Mutation

    D162E

    Promoter

    None

    Available Since

    April 24, 2017

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge